What does PHARMANUTRICS INTERNATIONAL do?

PHARMANUTRICS INTERNATIONAL is a wholesaler in Deerlijk. Private Limited, started on 18 November 2020, 1 establishment.

What is the address of PHARMANUTRICS INTERNATIONAL?

The registered office of PHARMANUTRICS INTERNATIONAL is located at Hoogstraat 45, 8540 Deerlijk.

Is PHARMANUTRICS INTERNATIONAL still active?

Yes. According to the CBE (29 October 2026) PHARMANUTRICS INTERNATIONAL is active, legal situation “Normale toestand”, started on 18 November 2020.

Is PHARMANUTRICS INTERNATIONAL registered on Peppol?

Yes, PHARMANUTRICS INTERNATIONAL is registered on the Peppol network with ID 0208:0758561081.

What is the enterprise number of PHARMANUTRICS INTERNATIONAL?

The enterprise number of PHARMANUTRICS INTERNATIONAL is BE0758561081.

When was PHARMANUTRICS INTERNATIONAL founded?

PHARMANUTRICS INTERNATIONAL was founded on 18 November 2020.

Who are the directors of PHARMANUTRICS INTERNATIONAL?

According to the 2025 annual accounts, the directors of PHARMANUTRICS INTERNATIONAL are: Nikolaas DEBUSSCHERE, Egwin PONETTE.

Is PHARMANUTRICS INTERNATIONAL a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 18 November 2020; 4 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did PHARMANUTRICS INTERNATIONAL make in 2025?

PHARMANUTRICS INTERNATIONAL recorded a loss after taxes of € 5,484 in financial year 2025.

What is the revenue of PHARMANUTRICS INTERNATIONAL?

As a small company, PHARMANUTRICS INTERNATIONAL is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -1,610.

PHARMANUTRICS INTERNATIONAL (Private Limited) - Deerlijk

Dossier PHARMANUTRICS INTERNATIONAL, printed on 29 October 2026 from databakkes.be/en/0758561081/pharmanutrics-international. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.

Financials

Financial year 2025

PHARMANUTRICS INTERNATIONAL from Deerlijk, company number BE0758561081, closed financial year 2025 with a result of € -5,484 after tax. For that financial year PHARMANUTRICS INTERNATIONAL recorded a gross margin of € -1,610 and equity of € 9,825. Compared with financial year 2024, the result moved from € -1,883 to € -5,484. The company made a loss. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on January 29, 2026.

What it is worth Healthy

€ 9,825

▼ 36% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -5,484

▼ 191 % more loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 3,178

▲ € 3,134 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -15,175.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 9,586

▲ € 9,541 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 2,270

▲ € 1,903 vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	-	-	€ 15,117 Revenue 2024: € 15,117 First fiscal year in the series	-
Gross margin	€ 3,460 Gross margin 2022: € 3,460 First fiscal year in the series	€ -1,375 Gross margin 2023: € -1,375 ▼ € 4,835 vs 2022 (€ 3,460) Unfavourable step	€ 1,757 Gross margin 2024: € 1,757 ▲ € 3,132 vs 2023 (€ -1,375) Favourable step	€ -1,610 Gross margin 2025: € -1,610 ▼ € 3,368 vs 2024 (€ 1,757) Unfavourable step	▼ € 3,368
Profit after taxes	€ -1,940 Profit after taxes 2022: € -1,940 First fiscal year in the series	€ -5,868 Profit after taxes 2023: € -5,868 ▼ € 3,928 vs 2022 (€ -1,940) Unfavourable step	€ -1,883 Profit after taxes 2024: € -1,883 ▲ € 3,985 vs 2023 (€ -5,868) Favourable step	€ -5,484 Profit after taxes 2025: € -5,484 ▼ € 3,601 vs 2024 (€ -1,883) Unfavourable step	▼ € 3,601
Equity	€ 23,060 Equity 2022: € 23,060 First fiscal year in the series	€ 17,192 Equity 2023: € 17,192 ▼ 25% vs 2022 (€ 23,060) Unfavourable step	€ 15,309 Equity 2024: € 15,309 ▼ 11% vs 2023 (€ 17,192) Unfavourable step	€ 9,825 Equity 2025: € 9,825 ▼ 36% vs 2024 (€ 15,309) Unfavourable step	▼ 36%
Total debts	€ 157,151 Total debts 2022: € 157,151 First fiscal year in the series	€ 164,432 Total debts 2023: € 164,432 ▲ 5% vs 2022 (€ 157,151) Unfavourable step	€ 166,759 Total debts 2024: € 166,759 ▲ 1% vs 2023 (€ 164,432) Unfavourable step	€ 182,885 Total debts 2025: € 182,885 ▲ 10% vs 2024 (€ 166,759) Unfavourable step	▲ 10%
Cash	€ 147 Cash 2022: € 147 First fiscal year in the series	€ 47 Cash 2023: € 47 ▼ 68% vs 2022 (€ 147) Unfavourable step	€ 43 Cash 2024: € 43 ▼ 7% vs 2023 (€ 47) Unfavourable step	€ 3,178 Cash 2025: € 3,178 ▲ € 3,134 vs 2024 (€ 43) Favourable step	▲ € 3,134
Retained profit	€ -1,940 Retained profit 2022: € -1,940 First fiscal year in the series	€ -7,808 Retained profit 2023: € -7,808 ▼ € 5,868 vs 2022 (€ -1,940) Unfavourable step	€ -9,691 Retained profit 2024: € -9,691 ▼ € 1,883 vs 2023 (€ -7,808) Unfavourable step	€ -15,175 Retained profit 2025: € -15,175 ▼ € 5,484 vs 2024 (€ -9,691) Unfavourable step	▼ € 5,484
Balance sheet total	€ 180,212 Balance sheet total 2022: € 180,212 First fiscal year in the series	€ 181,625 Balance sheet total 2023: € 181,625 ▲ 1% vs 2022 (€ 180,212) Unchanged	€ 182,068 Balance sheet total 2024: € 182,068 Unchanged (€ 181,625) Unchanged	€ 192,710 Balance sheet total 2025: € 192,710 ▲ 6% vs 2024 (€ 182,068) Unchanged	▲ 6%

Key figures of PHARMANUTRICS INTERNATIONAL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to PHARMANUTRICS INTERNATIONAL?

What happened at PHARMANUTRICS INTERNATIONAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jan 29, 2026 New annual accounts for financial year 2025: loss of € 5,484. Source: NBB ↗
Nov 18, 2020 New establishment in Deerlijk. KBO
Nov 18, 2020 Start of the company according to the CBE. KBO

In short

From € 1,940 loss in 2022 to € 5,484 loss in 2025.

Original PDFs at the National Bank ↗

Management

Nikolaas DEBUSSCHERE

Egwin PONETTE

PHARMANUTRICS INTERNATIONAL

Pharmanutrics USA 100%

Behind PHARMANUTRICS INTERNATIONAL are Nikolaas DEBUSSCHERE and Egwin PONETTE. It owns 100% of Pharmanutrics USA itself.

Directors

According to the 2025 annual accounts

Nikolaas DEBUSSCHERE

Director

Also active at: PharmaNutrics, APOTHEKERS BEKE-DEBUSSCHERE

Egwin PONETTE

Director

Also active at: Osteolab, PharmaNutrics, AV Medical

Establishments

Establishment units

Physical locations of this company

Registered office

Hoogstraat 45

8540 Deerlijk

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0758.561.081
VAT number: BE 0758.561.081
Registered office: Hoogstraat 45, 8540 Deerlijk
Names & denominations: PHARMANUTRICS INTERNATIONAL
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 18 November 2020
Peppol: Active · Active since 21 Oct 2026
Activities · NACE: Groothandel in andere voedingsmiddelen, neg

View on CBE Public ↗ Annual accounts (NBB) ↗